118 related articles for article (PubMed ID: 23500463)
41. Local production of serum amyloid a is implicated in the induction of macrophage chemoattractants in Schwann cells during wallerian degeneration of peripheral nerves.
Jang SY; Shin YK; Lee HY; Park JY; Suh DJ; Kim JK; Bae YS; Park HT
Glia; 2012 Oct; 60(10):1619-28. PubMed ID: 22777957
[TBL] [Abstract][Full Text] [Related]
42. Blocking toll-like receptors 7 and 9 reduces postinterventional remodeling via reduced macrophage activation, foam cell formation, and migration.
Karper JC; Ewing MM; Habets KL; de Vries MR; Peters EA; van Oeveren-Rietdijk AM; de Boer HC; Hamming JF; Kuiper J; Kandimalla ER; La Monica N; Jukema JW; Quax PH
Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):e72-80. PubMed ID: 22628437
[TBL] [Abstract][Full Text] [Related]
43. Serum amyloid A opposes lipoxin A₄ to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease.
Bozinovski S; Uddin M; Vlahos R; Thompson M; McQualter JL; Merritt AS; Wark PA; Hutchinson A; Irving LB; Levy BD; Anderson GP
Proc Natl Acad Sci U S A; 2012 Jan; 109(3):935-40. PubMed ID: 22215599
[TBL] [Abstract][Full Text] [Related]
44. Renoprotective effect of isoliquiritigenin on cisplatin-induced acute kidney injury through inhibition of FPR2 in macrophage.
Rui-Zhi T; Ke-Huan X; Yuan L; Xiao L; Bing-Wen Z; Tong-Tong L; Li W
J Pharmacol Sci; 2022 Jan; 148(1):56-64. PubMed ID: 34924130
[TBL] [Abstract][Full Text] [Related]
45. Serum Amyloid A Promotes E-Selectin Expression via Toll-Like Receptor 2 in Human Aortic Endothelial Cells.
Nishida E; Aino M; Kobayashi SI; Okada K; Ohno T; Kikuchi T; Hayashi JI; Yamamoto G; Hasegawa Y; Mitani A
Mediators Inflamm; 2016; 2016():7150509. PubMed ID: 27799725
[TBL] [Abstract][Full Text] [Related]
46. P55 tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice.
Xanthoulea S; Gijbels MJ; van der Made I; Mujcic H; Thelen M; Vergouwe MN; Ambagts MH; Hofker MH; de Winther MP
Cardiovasc Res; 2008 Nov; 80(2):309-18. PubMed ID: 18628255
[TBL] [Abstract][Full Text] [Related]
47. Lipoproteins, macrophage function, and atherosclerosis: beyond the foam cell?
Rader DJ; Puré E
Cell Metab; 2005 Apr; 1(4):223-30. PubMed ID: 16054067
[TBL] [Abstract][Full Text] [Related]
48. A membrane-tethering pepducin that inhibits formyl peptide receptor 2-induced signaling.
Lee HY; Kim H; Lee SY; Jung YS; Kim SD; Bae YS
Pharmazie; 2014 Apr; 69(4):293-6. PubMed ID: 24791594
[TBL] [Abstract][Full Text] [Related]
49. Calcium-independent phospholipase A2beta-Akt signaling is involved in lipopolysaccharide-induced NADPH oxidase 1 expression and foam cell formation.
Lee SH; Park DW; Park SC; Park YK; Hong SY; Kim JR; Lee CH; Baek SH
J Immunol; 2009 Dec; 183(11):7497-504. PubMed ID: 19917703
[TBL] [Abstract][Full Text] [Related]
50. Signal transducer and activator of transcription 1 is required for optimal foam cell formation and atherosclerotic lesion development.
Agrawal S; Febbraio M; Podrez E; Cathcart MK; Stark GR; Chisolm GM
Circulation; 2007 Jun; 115(23):2939-47. PubMed ID: 17533179
[TBL] [Abstract][Full Text] [Related]
51. Toll-like receptor-dependent lipid body formation in macrophage foam cell formation.
Nicolaou G; Erridge C
Curr Opin Lipidol; 2010 Oct; 21(5):427-33. PubMed ID: 20644474
[TBL] [Abstract][Full Text] [Related]
52. The FPR2-specific ligand MMK-1 activates the neutrophil NADPH-oxidase, but triggers no unique pathway for opening of plasma membrane calcium channels.
Karlsson J; Stenfeldt AL; Rabiet MJ; Bylund J; Forsman HF; Dahlgren C
Cell Calcium; 2009 May; 45(5):431-8. PubMed ID: 19282028
[TBL] [Abstract][Full Text] [Related]
53. Protein kinase C-eta and phospholipase D2 pathway regulates foam cell formation via regulator of G protein signaling 2.
Lee HK; Yeo S; Kim JS; Lee JG; Bae YS; Lee C; Baek SH
Mol Pharmacol; 2010 Sep; 78(3):478-85. PubMed ID: 20558593
[TBL] [Abstract][Full Text] [Related]
54. Foam cell formation of alveolar macrophages in Clara cell ablated mice inhaling crystalline silica.
Yatera K; Morimoto Y; Kim HN; Myojo T; Mukae H
Inhal Toxicol; 2011 Oct; 23(12):736-44. PubMed ID: 21967498
[TBL] [Abstract][Full Text] [Related]
55. Involvement of CD14 and toll-like receptor 4 in the acute phase response of serum amyloid A proteins and serum amyloid P component in the liver after burn injury.
Cho K; Pham TN; Crivello SD; Jeong J; Green TL; Greenhalgh DG
Shock; 2004 Feb; 21(2):144-50. PubMed ID: 14752288
[TBL] [Abstract][Full Text] [Related]
56. Structural characterization and inhibitory profile of formyl peptide receptor 2 selective peptides descending from a PIP2-binding domain of gelsolin.
Forsman H; Andréasson E; Karlsson J; Boulay F; Rabiet MJ; Dahlgren C
J Immunol; 2012 Jul; 189(2):629-37. PubMed ID: 22706076
[TBL] [Abstract][Full Text] [Related]
57. Pertussis Toxin Is a Robust and Selective Inhibitor of High Grade Glioma Cell Migration and Invasion.
Gilder AS; Wang L; Natali L; Karimi-Mostowfi N; Brifault C; Gonias SL
PLoS One; 2016; 11(12):e0168418. PubMed ID: 27977780
[TBL] [Abstract][Full Text] [Related]
58. The role of NF-кB in SAA-induced peroxisome proliferator-activated receptor γ activation.
Li H; Ooi SQ; Heng CK
Atherosclerosis; 2013 Mar; 227(1):72-8. PubMed ID: 23340376
[TBL] [Abstract][Full Text] [Related]
59. Leukocyte chemoattractant receptor FPR2 may accelerate atherogenesis.
Wan W; Gao JL
Med Hypotheses; 2012 Jul; 79(1):101-3. PubMed ID: 22541858
[TBL] [Abstract][Full Text] [Related]
60. COOH-terminal SAA1 peptides fail to induce chemokines but synergize with CXCL8 and CCL3 to recruit leukocytes via FPR2.
De Buck M; Gouwy M; Berghmans N; Opdenakker G; Proost P; Struyf S; Van Damme J
Blood; 2018 Jan; 131(4):439-449. PubMed ID: 29371208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
